Amedeo's Top 20

Amedeo Smart

Independent Medical Education

12 February 2024

Multidisciplinary Journal Club

  1. Chaker L, Cooper DS, Walsh JP, Peeters RP, et al.
    Hyperthyroidism.
    Lancet 2024.

  1. West EE, Woodruff T, Fremeaux-Bacchi V, Kemper C, et al.
    Complement in human disease: approved and up-and-coming therapeutics.
    Lancet 2024;403:392-405.

  2. Vagianos K, Dolovich C, Witges K, Graff LA, et al.
    Ultra-processed food, disease activity and inflammation in Ulcerative Colitis: The Manitoba Living with IBD Study.
    Am J Gastroenterol 2024.

  3. Hogman M, Bowerman C, Chavez L, Dressel H, et al.
    ERS technical standard: Global Lung Function Initiative reference values for exhaled nitric oxide fraction (F (ENO(50)) ).
    Eur Respir J 2024;63.

  4. Zampieri FG, Machado FR, Veiga VC, Azevedo LCP, et al.
    Determinants of fluid use and the association between volume of fluid used and effect of balanced solutions on mortality in critically ill patients: a secondary analysis of the BaSICS trial.
    Intensive Care Med 2024;50:79-89.

  1. Croce L, Teliti M, Chytiris S, Sparano C, et al.
    ATA risk classification of papillary thyroid cancer according to pre-surgery cytology.
    Eur J Endocrinol 2024.

  2. Armstrong WR, Kishan AU, Booker KM, Grogan TR, et al.
    Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774).
    Eur Urol 2024.

  3. Subramanian S, Khan F, Hirsch IB.
    New advances in type 1 diabetes.
    BMJ 2024;384:e075681.

  4. Lorenzen S, Gotze TO, Thuss-Patience P, Biebl M, et al.
    Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
    J Clin Oncol 2023.

  5. Kuchenbecker LA, Tipton PW, Martens Y, Brier MR, et al.
    Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia.
    Ann Neurol 2024;95:299-313.

  1. Gaillard T, Piketty J, Feron JG, Girard N, et al.
    Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib.
    Br J Cancer 2024.

  2. Dragoni G, Innocenti T, Amiot A, Castiglione F, et al.
    Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study.
    Am J Gastroenterol 2024.

  3. Guo A, Ludvigsson J, Brantsaeter AL, Klingberg S, et al.
    Early-life diet and risk of inflammatory bowel disease: a pooled study in two Scandinavian birth cohorts.
    Gut 2024.

  4. Lado FA, Ahrens SM, Riker E, Muh CR, et al.
    Guidelines for Specialized Epilepsy Centers: Executive Summary of the Report of the National Association of Epilepsy Centers Guideline Panel.
    Neurology 2024;102:e208087.

  5. Yao H, Zhang A, Li D, Wu Y, et al.
    Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis.
    BMJ 2024;384:e076410.

  1. Boue A, Joly F, Lequesne J, Lange M, et al.
    Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta-analysis.
    Cancer 2024.

  2. Prathibha S, White M, Kolbow M, Hui JYC, et al.
    Omission of axillary lymph node dissection for breast cancer patients with three or more positive sentinel lymph nodes.
    Breast Cancer Res Treat 2024.

  3. Ihara K, Schwedt TJ.
    Posttraumatic headache is a distinct headache type from migraine.
    Curr Opin Neurol 2024.

  4. Frederiksen KS, Morato X, Zetterberg H, Gauthier S, et al.
    Focusing on Earlier Management of Alzheimer Disease: Expert Opinion Based on a Modified Nominal Group Technique.
    Alzheimer Dis Assoc Disord 2024.

  5. Young E, Rajagopalan A, Tee D, Sathananthan D, et al.
    Texture and Color Enhancement Imaging Improves Colonic Adenoma Detection: A Multicenter Randomized Controlled Trial.
    Gastroenterology 2024;166:338-340.e3.


more..

Privacy Policy